Jim Cramer’s Stock Market Tips: Real Earnings, Share Updatesby Mark Eisenberg 28.03.2024Shares of WBA fell 1.6% in premarket trading, while BofA upgraded shares to buy from hold with a PT of ...
Goldman Predicts Upside for S&P 500by Terry Bingman 28.03.2024The hit rate of positive returns for S&P 500 dropped to 58% while the forward signal remains consistent with equal-weighted ...
Futures Dip as Braze Shares Tumble 14%by Terry Bingman 28.03.2024Braze shares plummeted 14%, while Jefferies stock slightly rose. IBM stock remains below its buy point. Google and ServiceNow stock ...
Cyngn Inc Financial Report: Stock Price Analysis 2024by Mark Eisenberg 28.03.2024Analyze Cyngn Inc's market performance & financial health. Get insights into stock prices, financial statements, & market predictions. Read more.
Virax Biolabs Group Ltd: Stock Soars 5.1% on NASDAQby Mark Eisenberg 28.03.2024Delve into the dynamic realm of biotech stocks with a detailed overview of Virax Biolabs Group Ltd on NASDAQ. Explore ...
Is the Stock Market Open Today? See Amended UK Trading Hoursby Terry Bingman 28.03.2024The London Stock Exchange (LSE) will have amended trading times during Easter 2024, with the market closing at 12:30pm. Morningstar's ...
Altitude Acquisition Corp: Financial Report Analysisby Terry Bingman 28.03.2024Discover the latest financial insights on Altitude Acquisition Corp (ALTU:NASDAQ) stock, including key data, historical trends, and price predictions. Stay ...
Stock Market Preview: 5 Things to Know Before Thursday Tradingby Mark Eisenberg 28.03.2024Shiny quarter sees best first-quarter gain in years, FTX founder indicted, Home Depot aims for professional market in ambitious move.
First Quarter Market Analysis: Record Smashes and Rate Cut Speculationby Mark Eisenberg 28.03.2024Traders anticipate the Fed will begin rate cuts this year as market records continue. Tech stocks stumble amidst Apple's sales ...
Dermira Stays Steady at $18.75 Amid Market Fluctuationsby Mark Eisenberg 28.03.2024Discover the financial insights of Dermira, a biopharmaceutical company, and gain a deeper understanding of their stock performance and market ...